GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
25 hedge funds and large institutions have $5.23M invested in Amplify Treatments, Testing and Advancements ETF in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$838K | |
| 2 | +$298K | |
| 3 | +$297K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$289K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$185K |
Top Sellers
| 1 | -$742K | |
| 2 | -$463K | |
| 3 | -$385K | |
| 4 |
CA
Clearstead Advisors
Cleveland,
Ohio
|
-$24K |
| 5 |
JWM
Jeppson Wealth Management
Manhattan Beach,
California
|
-$6K |